You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
復星醫藥AH股高開兼創歷史新高 子公司擬參與醫療保健供應商NFH私有化
格隆匯 08-05 09:32
格隆匯8月5日丨復星醫藥(2196.HK)高開4.22%,報80.25港元創歷史新高,最新市值2056億港元,該股今年迄今已累漲約1.2倍;復星醫藥(600196.SH)高開2.97%報90元,股價亦創歷史新高,該股年內已累漲近70%。復星醫藥昨日晚間公佈,NFH擬通過合併進行私有化並從紐交所退市,公司控股子公司復星實業擬作為私有化交易買方集團成員之一,以置換股份的方式參與此次私有化,即以截至公吿日所持有的全部NFH普通股(即940萬股,約佔截至2021年6月4日NFH已發行股份總數的7.1%)置換認購HoldCo(即合併後的NFH之間接控股股東)所發行普通股。如按HoldCo普通股認購價為12美元/股測算,預計緊隨此次私有化交易完成,HoldCo共計發行137,206,405股普通股,其中復星實業將持有HoldCo 940萬股普通股、約佔HoldCo已發行普通股總數的6.9%。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account